Status:
COMPLETED
Photobiomodulation for Breast Cancer Radiodermatitis
Lead Sponsor:
AC Camargo Cancer Center
Conditions:
Breast Cancer
Radiodermatitis
Eligibility:
FEMALE
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
A prospective single blind controlled randomized trial to evaluate the superiority of photobiomodulation (PBM) using LED-therapy in reducing the prevalence of radiodermatitis in breast cancer compared...
Detailed Description
Breast cancer is the second most common cancer in the world, the most common among women in Brazil and accounts for approximately 25% of new cases of cancer in women. One of the pillars of treatment i...
Eligibility Criteria
Inclusion
- Breast cancer
- Mastectomy or breast conserving surgery
- Informed consent
- Radiotherapy schedule completion
Exclusion
- Auto-immune disorders
- Immediate reconstruction
Key Trial Info
Start Date :
September 26 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 20 2021
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT04059809
Start Date
September 26 2018
End Date
July 20 2021
Last Update
August 13 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universidade do Vale do Itajai - UNIVALI
Itajaí, Santa Catarina, Brazil